Table 4: Comparison of the expression of four antibodies in patients with different insulin resistance status in Polyp group and Control group.
|
|
Polyp group |
Control group |
||
|
IR group (n = 20) |
NIR group (n = 32) |
IR group (n = 13) |
NIR group (n = 20) |
|
|
InR |
2.25 ± 0.64 |
2.27 ± 0.52 |
2.23 ± 0.44 |
2.10 ± 0.64 |
|
IGF-1R |
2.30 ± 0.57 |
2.24 ± 0.50 |
1.95 ± 0.49 |
2.10 ± 0.55 |
|
IRS-1 |
2.30 ± 0.57 |
2.24 ± 0.50 |
2.08 ± 0.76 |
2.05 ± 0.51 |
|
IRS-2 |
2.15 ± 0.59 |
2.27 ± 0.63 |
2.08 ± 0.76 |
2.15 ± 0.59 |